Microscopic polyangiitis: Advances in diagnostic and therapeutic approaches

Autoimmunity Reviews

Volumn 14, Issue 9, 2015, Pages 837-844

  Greco, Antonio ^a   De Virgilio, Armando ^a,b   Rizzo, Maria Ida ^a,b   Gallo, Andrea ^a   Magliulo, Giuseppe ^a   Fusconi, Massimo ^a   Ruoppolo, Giovanni ^a   Tombolini, Mario ^a   Turchetta, Rosaria ^a   de Vincentiis, Marco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antineutrophil cytoplasmic autoantibodies; Autoimmune vasculitis; Microscopic polyangiitis; Myeloperoxidase; Proteinase 3

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; AUTOANTIBODY;

ANTIBODY DETECTION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; LUNG BIOPSY; LUNG DISEASE; MICROSCOPIC POLYANGIITIS; NECROTIZING ARTERITIS; NEUROLOGIC DISEASE; PROGNOSIS; REMISSION; REVIEW; SKIN MANIFESTATION; ANIMAL;

ANIMALS; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MICROSCOPIC POLYANGIITIS; PROGNOSIS; REMISSION INDUCTION;

EID: 84938215862     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.05.005     Document Type: Review

References (76)

1. Falk R.J., Gross W.L., Guillevin L., Hoffman G.S., Jayne D.R., Jennette J.C., et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum 2011, 63:863-864.
2. Davies D.J., Moran J.E., Niall J.F., Ryan G.B. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?. Br Med J 1982, 285:606.
3. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
4. Greco A., Rizzo M.I., De Virgilio A., Gallo A., Fusconi M., Pagliuca G., et al. Goodpasture's syndrome: a clinical update. Autoimmun Rev 2015, 14:246-253.
5. Wohlwill F. Über die nur mikroskopisch erkennbare Form der Periarteritis nodosa. Virchows Arch Pathol Anat Physiol 1923, 246:36.
6. Godman G., Churg J. Wegener's granulomatosis: pathology and review of the literature. Arch Pathol Lab Med 1954, 58:533-553.
7. Savage C., Winearts C., Evans D., Rees A., Lockwood C. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985, 56:467e83.
8. Falk R., Jennette J. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318:1651.
9. Jennette J., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
10. Frankel S.K., Cosgrove G.P., Fischer A., Meehan R.T., Brown K.K. Update in the diagnosis and management of pulmonary vasculitis. Chest 2006, 129:452-465.
11. Chung S.A., Seo P. Microscopic polyangiitis. Rheum Dis Clin N Am 2010, 36:545-558.
12. Mohhmmad A.J., Jacobsson L.T., Mahr A.D., Sturfelt G., Segelmark M. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 2007, 46:1329-1337.
13. Guillevin L., Durand-Gasselin B., Cevallos R., Gayraud M., Lhote F., Callard P., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42:421-430.
14. Agard C., Mouthon L., Mahr A., Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?. Arthritis Rheum 2003, 49:709-715.
15. Lhote F., Cohen P., Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998, 7:238-258.
16. Mahr A., Guillevin L., Poissonnet M., Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51:92-99.
17. Koldingsnes W., Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000, 43:2481-2487.
18. Gonzalez-Gay M.A., Garcia-Porrua C., Guerrero J., Rodriguez-Ledo P., Llorca J. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003, 49:388-393.
19. Frankel S.K., Jayne D. The pulmonary vasculitides. Clin Chest Med 2010, 31:519-536.
20. Hogan S.L., Satterly K.K., Dooley M.A., Nachman P.H., Jennette J.C., Falk R.J. Silica exposure in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol 2001, 12:134e42.
21. Chen M., Kallenberg C.G. ANCA-associated vasculitides e advances in pathogenesis and treatment. Nat Rev Rheumatol 2010, 6:653e64.
22. Flossmann O., Berden A., de Groot K., Hagen C., Harper L., Heijl C., et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011, 70:488-494.
23. Hagen E.C., Daha M.R., Hermans J., Andrassy K., Csernok E., Lesavre P., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998, 53:743-753.
24. Terrier B., Saadoun D., Sane D., Ghillani P., Amoura Z., Deray G., et al. Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides. Ann Rheum Dis 2009, 68:1564e71.
25. Little M.A., Smyth C.L., Yadav R., Ambrose L., Cook H.T., Nourshargh S., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005, 106:2050-2058.
26. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:955-963.
27. Schlieben D.J., Korbet S.M., Kimura R.E., Schwartz M.M., Lewis E.J. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005, 45:758-761.
28. Silva F., Specks U., Sethi S., Irazabal M.V., Fervenza F.C. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis. Am J Kidney Dis 2009, 54:542-545.
29. Lyons P.A., Rayner T.F., Trivedi S., Holle J.U., Watts R.A., Jayne D.R., et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012, 367:214e23.
30. Kallenberg C.G.M., Stegeman C.A., Abdulahad W.H., Heeringa P. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Am J Kidney Dis 2013, 62:1176e87.
31. Wilke L., Prince-Fiocco M., Fiocco G.P. Microscopic polyangiitis: a large single-center series. J Clin Rheumatol 2014, 20:179-182.
32. Lauque D., Cadranel J., Lazor R., Pourrat J., Ronco P., Guillevin L., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 2000, 79:222-233.
33. Collins C.E., Quismorio F.P. Pulmonary involvement in microscopic polyangiitis. Curr Opin Pulm Med 2005, 11:447-451.
34. Franks T.J., Koss M.N. Pulmonary capillaritis. Curr Opin Pulm Med 2000, 6:430-435.
35. Eschun G.M., Mink S.N., Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003, 123:297-301.
36. Tzelepis G.E., Kokosi M., Tzioufas A., Toya S.P., Boki K.A., Zormpala A., et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010, 36:116-121.
37. Birnbaum J., Danoff S., Askin F.B., Stone J.H. Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?. Arthritis Rheum 2007, 56:2065-2071.
38. Gomez-Puerta J.A., Espinosa G., Morlà R., Cid M.C., Cervera R. Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil. Clin Exp Rheumatol 2009, 27:166-167.
39. Kluger N., Pagnoux C., Guillevin L., Francès C. French Vasculitis Study Group. Comparison of cutaneous manifestations in systemic polyarteritis nodosa and microscopic polyangiitis. Br J Dermatol 2008, 159:615-620.
40. Kawakami T., Soma Y., Saito C., Ogawa H., Nagahuchi Y., Okazaki T., et al. Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 2006, 86:144-147.
41. Pagnoux C., Mahr A., Cohen P., Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 2005, 84:115-128.
42. Guillevin L., Pagnoux C., Teixeira L. Microscopic polyangiitis. Vasculitis 2008, 355-364. Oxford University Press, Oxford. G. Ball, S. Bridges (Eds.).
43. Ueda S., Matsumoto M., Ahn T., Adachi S., Oku K., Takagi M., et al. Microscopic polyangiitis complicated with massive intestinal bleeding. J Gastroenterol 2001, 36:264-270.
44. Zhang W., Zhou G., Shi Q., Zhang X., Zeng X.F., Zhang F.C. Clinical analysis of nervous system involvement in ANCA-associated sistemi vasculitides. Clin Exp Rheumatol 2009, 27:S65-S69.
45. Hattori N., Mori K., Misu K., Koike H., Ichimura M., Sobue G. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatol 2002, 29:1408-1414.
46. Furukawa Y., Matsumoto Y., Yamada M. Hypertrophic pachymeningitis as an initial and cardinal manifestation of microscopic polyangiitis. Neurology 2004, 63:1722-1724.
47. Ku B.D., Shin H.Y. Multiple bilateral non-hemorrhagic cerebral infarctions associated with microscopic polyangiitis. Clin Neurol Neurosurg 2009, 111:904-906.
48. Adu D., Howie A.J., Scott D.G., Bacon P.A., McGonigle R.J., Micheal J. Polyarteritis and the kidney. Q J Med Mar 1987, 62:221-237.
49. Serra A., Cameron J., Turner D., Hartley B., Ogg C., Neild G., et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. QJM 1984, 53:181-207.
50. Veldman J. Immune-mediated sensorineural hearing loss. Auris Nasus Larynx 1998, 25:309-317.
51. Kallenberg C.G. The diagnosis and classification of microscopic polyangiitis. J Autoimmun 2014, 48-49:90-93.
52. Jennette J.C., Thomas D.B., Falk R.J. Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 2001, 18:3-13.
53. Savige J., Gillis D., Benson E., Davies D., Esnault V., Falk R.J., et al. International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999, 111:507-513.
54. Savige J., Dimech W., Fritzler M., Goeken J., Hagen E.C., Jennette J.C., et al. Addendum to the International Consensus Statement on testing and reporting of anti-neutrophil cytoplasmatic antibodies. Quality control guidelines, comments and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003, 120:312-314.
55. Russell K.A., Wiegert E., Schroeder D.R., Homburger H.A., Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol 2002, 103:196-203.
56. Csernok E., Moosig F. Current and emerging techniques for ANCA detection in vasculitis. Nat Rev Rheumatol 2014, 10:494-501.
57. Franssen C., Gans R., Kallenberg C., Hageluken C., Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 1998, 244:209-216.
58. Holle J.U., Hellmich B., Backes M., Gross W.L., Csernok E. Variations in performance characteristics of commercial enzyme immunoassay kits of the detection of antineutrophil cytoplasmatic antibodies: what is the optimal cut-off?. Ann Rheum Dis 2005, 64:1773-1779.
59. Hellmich B., Csernok E., Fredenhagen G., Gross W.L. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clin Exp Rheumatol 2007, 25:S1-S5.
60. Radice A., Bianchi L., Maggiore U., Vaglio A., Sinico R.A. Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener's). Clin Chem Lab Med 2013, 51:2141-2149.
61. Greco A., Rizzo M.I., De Virgilio A., Gallo A., Fusconi M., Ruoppolo G., et al. Churg-Strauss syndrome. Autoimmun Rev 2015, 14:341-348.
62. Falk R.J., Jennette J.C. ANCA small-vessel vasculitis. J Am Soc Nephrol 1997, 8:306-322.
63. Dringenberg C., Apenberg S., Andrassy K. P-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement. Adv Exp Med Biol 1993, 336:445-447.
64. Eisenberger U., Fakhouri F., Vanhille P., Beaufils H., Mahr A., Guillevin L., et al. ANCA negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 2005, 20:1392-1399.
65. Watts R., Lane S., Hanslik T., Hauser T., Hellmich B., Koldingsnes W., et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007, 66:222-227.
66. Niles J.L., Bottinger E.P., Saurina G.R., Kelly K.J., Pan G., Collins A.B., et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996, 156:440e5.
67. Fauci A., Wolff S. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine 1973, 52:53-61.
68. De Groot K., Harper L., Jayne D.R., Flores Suarez L.F., Gregorini G., Gross W.L., et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009, 150. [670-W119].
69. Falk R.J., Jennette J.C. ANCA disease: where is this field heading?. J Am Soc Nephrol 2010, 21:745-752.
70. Smith R.M., Jones R.B., Jayne D.R. Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther 2012, 14:210.
71. Millet A., Pederzoli-Ribeil M., Guillevin L., Witko-Sarsat V., Mouthon L. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?. Ann Rheum Dis 2013, 72:1273-1279.
72. Thurner L., Preuss K.D., Fadle N., Regitz E., Klemm P., Zaks M., et al. Progranulin antibodies in autoimmune diseases. J Autoimmun 2013, 42:29-38.
73. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
74. Calabrese L.H., Molloy E.S. Therapy: rituximab and PML risk-informed decisions needed!. Nat Rev Rheumatol 2009, 5:528-529.
75. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363:221-232.
76. Specks U., Merkel P.A., Seo P., Spiera R., Langford C.A., Hoffman G.S., et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 2013, 369:417-427.